ID
43735
Description
Trans-catheter Arterial Embolization Combined With p53 Gene Therapy for Treatment of Advanced Hepatocellular Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT02509169
Link
https://clinicaltrials.gov/show/NCT02509169
Keywords
Versions (2)
- 4/27/16 4/27/16 -
- 9/20/21 9/20/21 -
Uploaded on
September 20, 2021
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Advanced Hepatocellular Carcinoma (HCC) NCT02509169
Eligibility Advanced Hepatocellular Carcinoma (HCC) NCT02509169
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
hypersensitive to study drug
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0020517
- UMLS CUI [1,2]
- C0013175
Description
bleeding disorder, coagulation condition
Data type
boolean
Alias
- UMLS CUI [1]
- C3251812
- UMLS CUI [2]
- C0005779
Description
infections
Data type
boolean
Alias
- UMLS CUI [1]
- C0009450
Description
serious conditions
Data type
boolean
Alias
- UMLS CUI [1]
- C0525058
- UMLS CUI [2]
- C0009488
Description
pregnant or lactating
Data type
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
Similar models
Eligibility Advanced Hepatocellular Carcinoma (HCC) NCT02509169
- StudyEvent: Eligibility
C0013175 (UMLS CUI [1,2])
C0005779 (UMLS CUI [2])
C0009488 (UMLS CUI [2])
C0006147 (UMLS CUI [2])